US and Caribbean ハリケーンs blow a 穴を開ける in 医療の 器具／備品 会社／堅い Smith & 甥's 利益（をあげる）s

• e-mail

The 最近の ハリケーンs that 荒廃させるd large 列s of America and the Caribbean have cost 医療の 器具／備品 specialist Smith & 甥 about £4million after 手続きs had to be 延期するd in the US, Puerto Rico and Mexico.

As a result, the company, which makes 人工的な hips and 膝s, 推定する／予想するs 歳入 growth and 利益（をあげる） 利ざや 改良 to be at the lower end of 見積（る）s.

However, third ４半期/4分の1 歳入s were up three per cent on the year to £920m, just shy of market 予測（する）s, with its hip and 膝 implants up five per cent and 現れるing markets climbing nine per cent.

Counting the cost: The 最近の ハリケーンs that 荒廃させるd large swatches of America and the Caribbean have cost 医療の 器具／備品 specialist Smith & 甥 about £4m after 手続きs had to be 延期するd in the US, Puerto Rico and Mexico

改善するd 歳入 compared with the first half of the year was 予定 おもに to foreign 交流 movements.

Smith & 甥, which also has 負傷させる-care and sports 薬／医学 部隊s, had 以前 advised a 十分な-year 利ざや 改良 of between 0.2 to 0.7 百分率 points.

一方／合間, 去っていく／社交的な 長，指導者 (n)役員／(a)執行力のある Olivier Bohuon, who last month 発表するd 計画（する）s to retire next year, has 主張するd he has the 権利 戦略 for the company after coming under 圧力 to break it up by 行動主義者 投資家 Elliott 助言者s.

Bohuon said that he would put a ‘新たにするd 焦点（を合わせる） on 減ずるing cost’ and ‘簡単にするing’ the 商売／仕事 during his remaining 任期, 焦点（を合わせる）ing on 製造業の, 倉庫／問屋 and 配当 操作／手術s.

Two 報告（する）／憶測s last month said that Paul Singer's US hedge 基金 had taken a 火刑／賭ける in Smith & 甥, reigniting perennial 憶測 that it could be acquired by a 競争相手 such as Stryker or broken up.

Bouhon 拒絶する／低下するd to comment on ‘rumour or 憶測’ surrounding Elliott taking a 火刑／賭ける, but 機動力のある a 強健な defence of his 戦略.

‘This is a strong company and we believe 堅固に that this creates good value for all 株主s,’ he said.

Bouhon 追加するd: ‘We are not thinking about 資産 処分 at this 行う／開催する／段階 at all.’

Headded that he was ‘極端に excited about prospects in 現れるing markets’ - where it has been experiencing doubl e-digit growth - and argued that the 会社／堅い had ‘never been stronger than today’ in 研究 and 開発.

ーに関して／ーの点でs of その上の efficiency 伸び（る）s, Bohuon said the 会社／堅い would 乗る，着手する on a ‘second 一連の会議、交渉／完成する of 改良 to 簡単にする the company and make it more agile” and “改善する its 製造業の 足跡’.

Bold 計画（する）s: Two 報告（する）／憶測s last month said that Paul Singer's US hedge 基金 had taken a 火刑／賭ける in Smith & 甥, reigniting perennial 憶測 that it could be acquired by a 競争相手 such as Stryker or broken up

He 否定するd his 未解決の 退職 would be a distraction from 会合 the company’s goals, 説: ‘You do not know me 井戸／弁護士席. I will work until the last day of my 任期.’

Berenberg 分析家s said the numbers were ‘nothing stellar’ and 大部分は in line with 公正に／かなり low 期待s.

Berenberg, which has a 持つ／拘留する r ating on the 在庫／株, 追加するd that the efficiency programme is ありそうもない to be a game changer.

‘For the last １０年間 the company has more or いっそう少なく been 永久的に engaged in such a programme and while we do believe that on each occasion the company 達成するd its cost-saving goals, 利ざやs and 利益（をあげる） growth have not lived up to 投資家 期待s,’ the 仲買人 said.

Ian Forrest, 投資 研究 分析家 at The 株 Centre, said: “Healthcare group Smith & 甥 報告（する）／憶測d a third ４半期/4分の1 業績／成果 わずかに below 期待s today, but the market appears to have taken the news in its stride.

‘歳入s rose three per cent to $1.15bn with good growth in 現れるing markets and the 膝 implants 商売／仕事 stood out with a six per cent 増加する in sales.

井戸／弁護士席 支えるd: Smith & 甥's third ４半期/4分の1 歳入s were up 3% on the year to £920m, just shy of market 予測（する）s, with its hip and 膝 impla nts up 5% and 現れるing markets climbing 9%

‘The numbers might have been even better but the natural 災害s in the Americas have 延期するd some 医療の 手続きs and 前進するd 負傷させる care sales in Europe were weak. ‘The company said 十分な-year sales growth is now likely to come in に向かって the 底（に届く） of the three to four per cent 範囲 it gave 以前 and it has begun a review of its costs.’

He 追加するd: ‘Whilst the fact that the company 行方不明になるd 期待s today was disappointing it was only by a small 利ざや and the strength of 現れるing markets sales is encouraging.

‘The longer 称する，呼ぶ／期間／用語 drivers of growth remain in place so we continue to recommend Smith & 甥 as a “buy” for 投資家s 捜し出すing 資本／首都 growth and willing to 受託する a medium level of 危険.’

同様に as orthopaedics work, the 会社／堅い specialises in sports 薬／医学 and 負傷させる 装置s.

Smith & 甥 株 fell in 早期に 貿易（する）ing but 回復するd to rise 0.8 per cent to £13.94, having 攻撃する，衝突する a 記録，記録的な／記録する high of £14.42 last month.

?